187 related articles for article (PubMed ID: 32710129)
1. Rationale, Design, and Baseline Characteristics of the BioProsthetic Valves with Atrial Fibrillation (BPV-AF) Study.
Furukawa Y; Miyake M; Fujita T; Koyama T; Takegami M; Kimura T; Sugio K; Takita A; Nishimura K; Izumi C;
Cardiovasc Drugs Ther; 2020 Oct; 34(5):689-696. PubMed ID: 32710129
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic Therapy for Patients With Atrial Fibrillation and Bioprosthetic Valves - Real-World Data From the Multicenter, Prospective, Observational BPV-AF Registry.
Izumi C; Miyake M; Fujita T; Koyama T; Tanaka H; Ando K; Komiya T; Izumo M; Kawai H; Eishi K; Yoshida K; Kimura T; Nawada R; Sakamoto T; Shibata Y; Fukui T; Minatoya K; Tsujita K; Sakata Y; Takegami M; Kimura T; Sugio K; Takita A; Nishimura K; Furukawa Y;
Circ J; 2022 Feb; 86(3):440-448. PubMed ID: 34719560
[TBL] [Abstract][Full Text] [Related]
3. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH
J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508
[TBL] [Abstract][Full Text] [Related]
4. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.
Lip GYH; Jensen M; Melgaard L; Skjøth F; Nielsen PB; Larsen TB
Europace; 2019 Jan; 21(1):33-40. PubMed ID: 29986001
[TBL] [Abstract][Full Text] [Related]
5. How to define valvular atrial fibrillation?
Fauchier L; Philippart R; Clementy N; Bourguignon T; Angoulvant D; Ivanes F; Babuty D; Bernard A
Arch Cardiovasc Dis; 2015 Oct; 108(10):530-9. PubMed ID: 26184867
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial.
Guimarães PO; Pokorney SD; Lopes RD; Wojdyla DM; Gersh BJ; Giczewska A; Carnicelli A; Lewis BS; Hanna M; Wallentin L; Vinereanu D; Alexander JH; Granger CB
Clin Cardiol; 2019 May; 42(5):568-571. PubMed ID: 30907005
[TBL] [Abstract][Full Text] [Related]
7. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
[TBL] [Abstract][Full Text] [Related]
8. Registry of antithrombotic therapy in atrial fibrillation patients with bioprosthetic valves: A retrospective observational study.
Izumi C; Miyake M; Amano M; Kitai T; Obayashi Y; Takegami M; Kimura T; Sugio K; Matsumoto T; Nishimura K; Furukawa Y
J Cardiol; 2020 Jul; 76(1):44-50. PubMed ID: 32156512
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of novel oral anticoagulants in patients with bioprosthetic valves.
Yadlapati A; Groh C; Malaisrie SC; Gajjar M; Kruse J; Meyers S; Passman R
Clin Res Cardiol; 2016 Mar; 105(3):268-72. PubMed ID: 26384981
[TBL] [Abstract][Full Text] [Related]
10. Impact of mitral versus aortic bioprosthetic valve position on thromboembolism and bleeding risk in patients with atrial fibrillation.
Obayashi Y; Miyake M; Amano M; Kitai T; Takegami M; Nishimura K; Tamura T; Furukawa Y; Izumi C
J Cardiol; 2022 Feb; 79(2):226-232. PubMed ID: 34716054
[TBL] [Abstract][Full Text] [Related]
11. Stroke prevention strategies in patients with atrial fibrillation and heart valve abnormalities: perceptions of 'valvular' atrial fibrillation: results of the European Heart Rhythm Association Survey.
Potpara TS; Lip GY; Larsen TB; Madrid A; Dobreanu D; Jędrzejczyk-Patej E; Dagres N;
Europace; 2016 Oct; 18(10):1593-1598. PubMed ID: 27876696
[TBL] [Abstract][Full Text] [Related]
12. Oral anticoagulants in atrial fibrillation with valvular heart disease and bioprosthetic heart valves.
Malik AH; Yandrapalli S; Aronow WS; Panza JA; Cooper HA
Heart; 2019 Sep; 105(18):1432-1436. PubMed ID: 31203254
[TBL] [Abstract][Full Text] [Related]
13. Preoperative paroxysmal atrial fibrillation predicts high cardiovascular mortality in patients undergoing surgical aortic valve replacement with a bioprosthesis: CAREAVR study.
Nissinen M; Lehto J; Biancari F; Nieminen T; Malmberg M; Yannopoulos F; Salmi S; Airaksinen JKE; Kiviniemi T; Hartikainen JEK
Clin Cardiol; 2020 Apr; 43(4):401-409. PubMed ID: 32022308
[TBL] [Abstract][Full Text] [Related]
14. Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: data from the GISSI-AF trial.
Disertori M; Franzosi MG; Barlera S; Cosmi F; Quintarelli S; Favero C; Cappellini G; Fabbri G; Maggioni AP; Staszewsky L; Moroni LA; Latini R;
BMC Cardiovasc Disord; 2013 Apr; 13():28. PubMed ID: 23586654
[TBL] [Abstract][Full Text] [Related]
15. Impact of Valvular Heart Disease on Mortality, Thromboembolic and Cardiac Events in Japanese Patients With Atrial Fibrillation - The Fushimi AF Registry.
Doi K; Ogawa H; Ishigami K; Ikeda S; Aono Y; Hamatani Y; Fujino A; An Y; Ishii M; Iguchi M; Masunaga N; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Akao M;
Circ J; 2020 Apr; 84(5):714-722. PubMed ID: 32213725
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic Therapy and Cardiovascular Outcomes After Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation.
Kosmidou I; Liu Y; Alu MC; Liu M; Madhavan M; Chakravarty T; Makkar R; Thourani VH; Biviano A; Kodali S; Leon MB
JACC Cardiovasc Interv; 2019 Aug; 12(16):1580-1589. PubMed ID: 31439338
[TBL] [Abstract][Full Text] [Related]
17. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and antithrombotic treatment patterns of patients with concomitant coronary artery disease and atrial fibrillation from Thailand's COOL-AF registry.
Winijkul A; Kaewkumdee P; Yindeengam A; Krittayaphong R
BMC Cardiovasc Disord; 2021 Mar; 21(1):117. PubMed ID: 33653277
[TBL] [Abstract][Full Text] [Related]
19. Direct Oral Anticoagulation Versus Warfarin in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves: a Retrospective, Real-World Cohort Study.
Eikelboom R; Whitlock RP; Sibilio S; Nguyen F; Perez R; Weitz JI; Belley-Cote E
Cardiovasc Drugs Ther; 2024 Feb; 38(1):109-117. PubMed ID: 36121587
[TBL] [Abstract][Full Text] [Related]
20. Early Antithrombotic Therapy after Bioprosthetic Aortic Valve Replacement in Elderly Patients: A Single-Center Experience.
Lee SI; Lee KS; Kim JB; Choo SJ; Chung CH; Lee JW; Jung SH
Ann Thorac Cardiovasc Surg; 2017 Jun; 23(3):128-134. PubMed ID: 28367855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
